Irp2 regulates insulin production through iron-mediated Cdkal1-catalyzed tRNA modification.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
15 01 2020
Historique:
received: 03 12 2018
accepted: 06 12 2019
entrez: 17 1 2020
pubmed: 17 1 2020
medline: 14 4 2020
Statut: epublish

Résumé

Regulation of cellular iron homeostasis is crucial as both iron excess and deficiency cause hematological and neurodegenerative diseases. Here we show that mice lacking iron-regulatory protein 2 (Irp2), a regulator of cellular iron homeostasis, develop diabetes. Irp2 post-transcriptionally regulates the iron-uptake protein transferrin receptor 1 (TfR1) and the iron-storage protein ferritin, and dysregulation of these proteins due to Irp2 loss causes functional iron deficiency in β cells. This impairs Fe-S cluster biosynthesis, reducing the function of Cdkal1, an Fe-S cluster enzyme that catalyzes methylthiolation of t

Identifiants

pubmed: 31941883
doi: 10.1038/s41467-019-14004-5
pii: 10.1038/s41467-019-14004-5
pmc: PMC6962211
doi:

Substances chimiques

Insulin 0
Iron-Sulfur Proteins 0
RNA, Transfer, Lys 0
Proinsulin 9035-68-1
Iron E1UOL152H7
tRNA Methyltransferases EC 2.1.1.-
CDKAL1 protein, mouse EC 2.8.4.5
Ireb2 protein, mouse EC 4.2.1.3
Iron Regulatory Protein 2 EC 4.2.1.3

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

296

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM045201
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK107712
Pays : United States
Organisme : NIDDK NIH HHS
ID : U54 DK110858
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007115
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES002109
Pays : United States

Références

Rajpathak, S. N. et al. The role of iron in type 2 diabetes in humans. Biochim. Biophys. Acta 1790, 671–681 (2009).
pubmed: 18501198 doi: 10.1016/j.bbagen.2008.04.005 pmcid: 18501198
Simcox, J. A. & McClain, D. A. Iron and diabetes risk. Cell Metab. 17, 329–341 (2013).
pubmed: 23473030 pmcid: 3648340 doi: 10.1016/j.cmet.2013.02.007
Backe, M. B., Moen, I. W., Ellervik, C., Hansen, J. B. & Mandrup-Poulsen, T. Iron regulation of pancreatic beta-cell functions and oxidative stress. Annu. Rev. Nutr. 36, 241–273 (2016).
pubmed: 27146016 doi: 10.1146/annurev-nutr-071715-050939 pmcid: 27146016
Hansen, J. B. et al. Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic beta cell fate in response to cytokines. Cell Metab. 16, 449–461 (2012).
pubmed: 23000401 doi: 10.1016/j.cmet.2012.09.001 pmcid: 23000401
Cooksey, R. C. et al. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 145, 5305–5312 (2004).
pubmed: 15308612 doi: 10.1210/en.2004-0392 pmcid: 15308612
Ristow, M. et al. Frataxin deficiency in pancreatic islets causes diabetes due to loss of beta cell mass. J. Clin. Invest. 112, 527–534 (2003).
pubmed: 12925693 pmcid: 171391 doi: 10.1172/JCI18107
Braymer, J. J. & Lill, R. Iron-sulfur cluster biogenesis and trafficking in mitochondria. J. Biol. Chem. 292, 12754–12763 (2017).
pubmed: 28615445 pmcid: 5546016 doi: 10.1074/jbc.R117.787101
Netz, D. J., Mascarenhas, J., Stehling, O., Pierik, A. J. & Lill, R. Maturation of cytosolic and nuclear iron-sulfur proteins. Trends Cell Biol. 24, 303–312 (2014).
pubmed: 24314740 doi: 10.1016/j.tcb.2013.11.005 pmcid: 24314740
Rouault, T. A. Mammalian iron-sulphur proteins: novel insights into biogenesis and function. Nat. Rev. Mol. Cell Biol. 16, 45–55 (2015).
pubmed: 25425402 doi: 10.1038/nrm3909 pmcid: 25425402
Rouault, T. A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat. Chem. Biol. 2, 406–414 (2006).
pubmed: 16850017 doi: 10.1038/nchembio807 pmcid: 16850017
Hentze, M. W., Muckenthaler, M. U., Galy, B. & Camaschella, C. Two to tango: regulation of Mammalian iron metabolism. Cell 142, 24–38 (2010).
pubmed: 20603012 doi: 10.1016/j.cell.2010.06.028 pmcid: 20603012
Anderson, C. P., Shen, M., Eisenstein, R. S. & Leibold, E. A. Mammalian iron metabolism and its control by iron regulatory proteins. Biochim. Biophys. Acta 1823, 1468–1483 (2012).
pubmed: 22610083 pmcid: 3675657 doi: 10.1016/j.bbamcr.2012.05.010
Vashisht, A. A. et al. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science 326, 718–721 (2009).
pubmed: 19762596 pmcid: 2929180 doi: 10.1126/science.1176333
Salahudeen, A. A. et al. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science 326, 722–726 (2009).
pubmed: 19762597 pmcid: 3582197 doi: 10.1126/science.1176326
Cooperman, S. S. et al. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2. Blood 106, 1084–1091 (2005).
pubmed: 15831703 pmcid: 1895161 doi: 10.1182/blood-2004-12-4703
Galy, B. et al. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2). Blood 106, 2580–2589 (2005).
pubmed: 15956281 doi: 10.1182/blood-2005-04-1365 pmcid: 15956281
Zumbrennen-Bullough, K. B. et al. Abnormal brain iron metabolism in Irp2 deficient mice is associated with mild neurological and behavioral impairments. PLoS ONE 9, e98072 (2014).
pubmed: 24896637 pmcid: 4045679 doi: 10.1371/journal.pone.0098072
Jeong, S. Y. et al. Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice. PLoS ONE 6, e25404 (2011).
pubmed: 22003390 pmcid: 3189198 doi: 10.1371/journal.pone.0025404
Arragain, S. et al. Identification of eukaryotic and prokaryotic methylthiotransferase for biosynthesis of 2-methylthio-N6-threonylcarbamoyladenosine in tRNA. J. Biol. Chem. 285, 28425–28433 (2010).
pubmed: 20584901 pmcid: 2937867 doi: 10.1074/jbc.M110.106831
Wei, F. Y. et al. Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice. J. Clin. Invest. 121, 3598–3608 (2011).
pubmed: 21841312 pmcid: 3163968 doi: 10.1172/JCI58056
Steinthorsdottir, V. et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet. 39, 770–775 (2007).
pubmed: 17460697 doi: 10.1038/ng2043 pmcid: 17460697
Diabetes Genetics Initiative of Broad Institute of, H. et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331–1336 (2007).
doi: 10.1126/science.1142358
Scott, L. J. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341–1345 (2007).
pubmed: 17463248 pmcid: 3214617 doi: 10.1126/science.1142382
Zeggini, E. et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316, 1336–1341 (2007).
pubmed: 17463249 pmcid: 3772310 doi: 10.1126/science.1142364
Galy, B. et al. Iron regulatory proteins secure mitochondrial iron sufficiency and function. Cell Metab. 12, 194–201 (2010).
pubmed: 20674864 doi: 10.1016/j.cmet.2010.06.007 pmcid: 20674864
Arunagiri, A. et al. Misfolded proinsulin in the endoplasmic reticulum during development of beta cell failure in diabetes. Ann. N. Y Acad. Sci. 1418, 5–19 (2018).
pubmed: 29377149 pmcid: 5934315 doi: 10.1111/nyas.13531
Back, S. H. & Kaufman, R. J. Endoplasmic reticulum stress and type 2 diabetes. Annu. Rev. Biochem. 81, 767–793 (2012).
pubmed: 22443930 pmcid: 3684428 doi: 10.1146/annurev-biochem-072909-095555
Papa, F. R. Endoplasmic reticulum stress, pancreatic beta-cell degeneration, and diabetes. Cold Spring Harb. Perspect. Med. 2, a007666 (2012).
pubmed: 22951443 pmcid: 3426819 doi: 10.1101/cshperspect.a007666
Brambillasca, S. et al. CDK5 regulatory subunit-associated protein 1-like 1 (CDKAL1) is a tail- anchored protein in the endoplasmic reticulum (ER) of insulinoma cells. J. Biol. Chem. 287, 41808–41819 (2012).
pubmed: 23048041 pmcid: 3516729 doi: 10.1074/jbc.M112.376558
Lill, R., Srinivasan, V. & Muhlenhoff, U. The role of mitochondria in cytosolic-nuclear iron-sulfur protein biogenesis and in cellular iron regulation. Curr. Opin. Microbiol. 22C, 111–119 (2014).
doi: 10.1016/j.mib.2014.09.015
Koshimizu, H., Kim, T., Cawley, N. X. & Loh, Y. P. Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis. Regul. Pept. 160, 153–159 (2010).
pubmed: 20006653 doi: 10.1016/j.regpep.2009.12.007 pmcid: 20006653
Groenewoud, M. J. et al. Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia 51, 1659–1663 (2008).
pubmed: 18618095 doi: 10.1007/s00125-008-1083-z pmcid: 18618095
Stancakova, A. et al. Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance. J. Clin. Endocrinol. Metab. 93, 1924–1930 (2008).
pubmed: 18285412 doi: 10.1210/jc.2007-2218 pmcid: 18285412
Kirchhoff, K. et al. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 51, 597–601 (2008).
pubmed: 18264689 doi: 10.1007/s00125-008-0926-y pmcid: 18264689
Pascoe, L. et al. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 56, 3101–3104 (2007).
pubmed: 17804762 doi: 10.2337/db07-0634 pmcid: 17804762
Oslowski, C. M. & Urano, F. The binary switch that controls the life and death decisions of ER stressed beta cells. Curr. Opin. Cell Biol. 23, 207–215 (2011).
pubmed: 21168319 doi: 10.1016/j.ceb.2010.11.005
Muoio, D. M. & Newgard, C. B. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9, 193–205 (2008).
pubmed: 18200017 doi: 10.1038/nrm2327
Ohara-Imaizumi, M. et al. Deletion of CDKAL1 affects mitochondrial ATP generation and first-phase insulin exocytosis. PLoS ONE 5, e15553 (2010).
pubmed: 21151568 pmcid: 3000340 doi: 10.1371/journal.pone.0015553
Gabrielsen, J. S. et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J. Clin. Invest. 122, 3529–3540 (2012).
pubmed: 22996660 pmcid: 3461897 doi: 10.1172/JCI44421
Gao, Y. et al. Adipocyte iron regulates leptin and food intake. J. Clin. Invest. 125, 3681–3691 (2015).
pubmed: 26301810 pmcid: 4588289 doi: 10.1172/JCI81860
Hussain, M. A., Akalestou, E. & Song, W. J. Inter-organ communication and regulation of beta cell function. Diabetologia 59, 659–667 (2016).
pubmed: 26791990 pmcid: 4801104 doi: 10.1007/s00125-015-3862-7
Cantley, J. The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signalling in metabolic homeostasis. Mamm. Genome 25, 442–454 (2014).
pubmed: 25146550 doi: 10.1007/s00335-014-9538-7 pmcid: 25146550
Tao, C., Sifuentes, A. & Holland, W. L. Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic beta cells and adipocytes. Best. Pract. Res. Clin. Endocrinol. Metab. 28, 43–58 (2014).
pubmed: 24417945 doi: 10.1016/j.beem.2013.11.003 pmcid: 24417945
Take, K. et al. CDK5 regulatory subunit-associated protein 1-like 1 negatively regulates adipocyte differentiation through activation of Wnt signaling pathway. Sci. Rep. 7, 7326 (2017).
pubmed: 28779110 pmcid: 5544666 doi: 10.1038/s41598-017-06469-5
Palmer, C. J. et al. Cdkal1, a type 2 diabetes susceptibility gene, regulates mitochondrial function in adipose tissue. Mol. Metab. 6, 1212–1225 (2017).
pubmed: 29031721 pmcid: 5641635 doi: 10.1016/j.molmet.2017.07.013
Takesue, Y. et al. Regulation of growth hormone biosynthesis by Cdk5 regulatory subunit associated protein 1-like 1 (CDKAL1) in pituitary adenomas. Endocr. J. 66, 807–816 (2019).
pubmed: 31189758 doi: 10.1507/endocrj.EJ18-0536 pmcid: 31189758
Zhou, Y. et al. Iron regulatory protein 2 deficiency may correlate with insulin resistance. Biochem. Biophys. Res. Commun. 510, 191–197 (2019).
pubmed: 30685084 doi: 10.1016/j.bbrc.2019.01.022 pmcid: 30685084
Larrick, J. W. & Hyman, E. S. Acquired iron-deficiency anemia caused by an antibody against the transferrin receptor. N. Engl. J. Med. 311, 214–218 (1984).
pubmed: 6330553 doi: 10.1056/NEJM198407263110402 pmcid: 6330553
Hyman, E. S. Acquired iron-deficiency anaemia due to impaired iron transport. Lancet 1, 91–95 (1983).
pubmed: 6129457 doi: 10.1016/S0140-6736(83)91741-5 pmcid: 6129457
Rhodes, C. J. et al. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. J. Am. Coll. Cardiol. 58, 300–309 (2011).
pubmed: 21737024 doi: 10.1016/j.jacc.2011.02.057 pmcid: 21737024
Ruiter, G. et al. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur. Respir. J. 37, 1386–1391 (2011).
pubmed: 20884742 doi: 10.1183/09031936.00100510 pmcid: 20884742
van Empel, V. P., Lee, J., Williams, T. J. & Kaye, D. M. Iron deficiency in patients with idiopathic pulmonary arterial hypertension. Heart Lung Circ. 23, 287–292 (2014).
pubmed: 24094431 doi: 10.1016/j.hlc.2013.08.007 pmcid: 24094431
von Haehling, S., Jankowska, E. A., van Veldhuisen, D. J., Ponikowski, P. & Anker, S. D. Iron deficiency and cardiovascular disease. Nat. Rev. Cardiol. 12, 659–669 (2015).
doi: 10.1038/nrcardio.2015.109
Visanji, N. P. et al. Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson’s disease and multiple system atrophy. J. Parkinsons Dis. 3, 523–537 (2013).
pubmed: 24113558 doi: 10.3233/JPD-130197 pmcid: 24113558
Cotroneo, E. et al. Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat. Circ. Res. 116, 1680–1690 (2015).
pubmed: 25767292 doi: 10.1161/CIRCRESAHA.116.305265 pmcid: 25767292
Matak, P. et al. Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice. Proc. Natl Acad. Sci. USA 113, 3428–3435 (2016).
pubmed: 26929359 doi: 10.1073/pnas.1519473113 pmcid: 26929359
Cooper, M. S., Stark, Z., Lunke, S., Zhao, T. & Amor, D. J. IREB2-associated neurodegeneration. Brain 142, e40 (2019).
pubmed: 31243445 doi: 10.1093/brain/awz183 pmcid: 31243445
Costain, G. et al. Absence of iron-responsive element-binding protein 2 causes a novel neurodegenerative syndrome. Brain 142, 1195–1202 (2019).
pubmed: 30915432 doi: 10.1093/brain/awz072 pmcid: 30915432
Galy, B., Ferring-Appel, D., Kaden, S., Grone, H. J. & Hentze, M. W. Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Metab. 7, 79–85 (2008).
pubmed: 18177727 doi: 10.1016/j.cmet.2007.10.006 pmcid: 18177727
Neschen, S. et al. Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl- CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. Cell Metab. 2, 55–65 (2005).
pubmed: 16054099 doi: 10.1016/j.cmet.2005.06.006 pmcid: 16054099
Neschen, S. et al. n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator- activated receptor-alpha-dependent manner. Diabetes 56, 1034–1041 (2007).
pubmed: 17251275 doi: 10.2337/db06-1206 pmcid: 17251275
Hohmeier, H. E. et al. Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel- dependent and -independent glucose-stimulated insulin secretion. Diabetes 49, 424–430 (2000).
pubmed: 10868964 doi: 10.2337/diabetes.49.3.424 pmcid: 10868964
Zimmer, M. et al. Small-molecule inhibitors of HIF-2a translation link its 5’UTR iron-responsive element to oxygen sensing. Mol. Cell 32, 838–848 (2008).
pubmed: 19111663 pmcid: 3978139 doi: 10.1016/j.molcel.2008.12.004
Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281–2308 (2013).
pubmed: 24157548 pmcid: 3969860 doi: 10.1038/nprot.2013.143
Guo, B., Yu, Y. & Leibold, E. A. Iron regulates cytoplasmic levels of a novel iron-responsive element- binding protein without aconitase activity. J. Biol. Chem. 269, 24252–24260 (1994).
pubmed: 7523370 pmcid: 7523370
Leibold, E. A. & Munro, H. N. Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5’ untranslated region of ferritin heavy- and light-subunit mRNAs. Proc. Natl Acad. Sci. USA 85, 2171–2175 (1988).
pubmed: 3127826 doi: 10.1073/pnas.85.7.2171 pmcid: 3127826
Beaumont, C., Torti, S. V., Torti, F. M. & Massover, W. H. Novel properties of L-type polypeptide subunits in mouse ferritin molecules. J. Biol. Chem. 271, 7923–7926 (1996).
pubmed: 8626471 doi: 10.1074/jbc.271.14.7923 pmcid: 8626471
Vendeix, F. A. et al. Human tRNA(Lys3)(UUU) is pre-structured by natural modifications for cognate and wobble codon binding through keto-enol tautomerism. J. Mol. Biol. 416, 467–485 (2012).
pubmed: 22227389 doi: 10.1016/j.jmb.2011.12.048 pmcid: 22227389

Auteurs

Maria C Ferreira Dos Santos (MCFD)

Department of Medicine, Division of Hematology, University of Utah, Salt Lake City, UT, 84112, USA.
Molecular Medicine Program, University of Utah, Salt Lake City, UT, 84112, USA.

Cole P Anderson (CP)

Molecular Medicine Program, University of Utah, Salt Lake City, UT, 84112, USA.
Department of Oncological Sciences, University of Utah, Salt Lake City, UT, 84112, USA.
Landstuhl Regional Medical Center, 66849, Landstuhl, Germany.

Susanne Neschen (S)

German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
German Center for Diabetes Research (DZD), Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.

Kimberly B Zumbrennen-Bullough (KB)

Molecular Medicine Program, University of Utah, Salt Lake City, UT, 84112, USA.
Department of Oncological Sciences, University of Utah, Salt Lake City, UT, 84112, USA.

Steven J Romney (SJ)

Department of Medicine, Division of Hematology, University of Utah, Salt Lake City, UT, 84112, USA.
Molecular Medicine Program, University of Utah, Salt Lake City, UT, 84112, USA.
Thermo Fisher Scientific, Waltham, MA, 02451, USA.

Melanie Kahle-Stephan (M)

German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
Medizinische Hochschule Brandenburg Theodor Fontane Institut für Sozialmedizin und Epidemiologie, 14770, Brandenburg an der Havel, Germany.

Birgit Rathkolb (B)

German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
German Center for Diabetes Research (DZD), Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
Institute of Molecular Animal Breeding and Biotechnology, Gene Center, Ludwig-Maximilians-Universität München, Feodor-Lynen Strasse 25, 81377, Munich, Germany.

Valerie Gailus-Durner (V)

German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.

Helmut Fuchs (H)

German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.

Eckhard Wolf (E)

Institute of Molecular Animal Breeding and Biotechnology, Gene Center, Ludwig-Maximilians-Universität München, Feodor-Lynen Strasse 25, 81377, Munich, Germany.

Jan Rozman (J)

German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
German Center for Diabetes Research (DZD), Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prumyslova, 595, 252 50 Vestec, Czech Republic.

Martin Hrabe de Angelis (MH)

German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
German Center for Diabetes Research (DZD), Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
Chair of Experimental Genetics, School of Life Science Weihenstephan, Technische Universität München, Alte Akademie 8, 85354, Freising, Germany.

Weiling Maggie Cai (WM)

Department of Microbiology, National University of Singapore, Singapore, Singapore, 119077.
Antimicrobial Resistance Interdisciplinary Research Group (IRG), Singapore-MIT Alliance for Research and Technology, 1 CREATE Way, Singapore, Singapore, 138602.
Agilent Technologies, 1 Yishun Ave 7, Singapore, Singapore, 768923.

Malini Rajan (M)

Department of Medicine, Division of Hematology, University of Utah, Salt Lake City, UT, 84112, USA.
Molecular Medicine Program, University of Utah, Salt Lake City, UT, 84112, USA.

Jennifer Hu (J)

Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Celgene Corporation, 1616 Eastlake Ave East, Seattle, WA, 98102, USA.

Peter C Dedon (PC)

Antimicrobial Resistance Interdisciplinary Research Group (IRG), Singapore-MIT Alliance for Research and Technology, 1 CREATE Way, Singapore, Singapore, 138602.
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.

Elizabeth A Leibold (EA)

Department of Medicine, Division of Hematology, University of Utah, Salt Lake City, UT, 84112, USA. betty.leibold@genetics.utah.edu.
Molecular Medicine Program, University of Utah, Salt Lake City, UT, 84112, USA. betty.leibold@genetics.utah.edu.
Department of Oncological Sciences, University of Utah, Salt Lake City, UT, 84112, USA. betty.leibold@genetics.utah.edu.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH